News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
3333
Sources here
15
Companies here
29
Search results Stored financial headlines

Active search

3333 matching headlines

Ticker or company: TMMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Clover Health's Q2 Earnings Call Clover Health's second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter's performance to the expansion of its …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Atmus Filtration Technologies Inc. (NYSE:ATMU) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Atmus Filtration Technologies (NYSE:ATMU) reported strong second-quarter results, with revenues and EPS exceeding analyst expectations. Analysts have maintained their revenue and EPS forecasts for 2026, suggesting no significant change in sentiment despite the positive results. The company is projected to accelerate its revenue growth, …

ATMU main company
Sharemaestro market context Price below Trend Line 52 weeks +16.6% · Next-week setup positive 60.9% ATMU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TMC the metals company Inc (TMC) Stock Price Live, Chart & News - TradingKey

This article provides a detailed financial overview of TMC the metals company Inc (TMC), including live stock price data, key figures, analyst ratings, and technical analysis. It highlights the company's focus on deep-sea minerals exploration for polymetallic nodules containing metals essential for EV and …

TMC main company
Sharemaestro market context Price below Trend Line 52 weeks -17.5% · Next-week setup negative 38.4% TMC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aehr Test Systems $AEHR Shares Sold by Sei Investments Co.

Sei Investments Co. reduced its stake in Aehr Test Systems (NASDAQ:AEHR) by 27.6% in the first quarter, selling 8,812 shares but retaining 23,109 shares valued at $857,000. Despite this, institutional investors and hedge funds still own a significant 69.69% of AEHR. The company has …

SEIC main company
Sharemaestro market context Trend signal active 52 weeks +19.4% SEIC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Makes New Investment in Aclaris Therapeutics, Inc. $ACRS

Sei Investments Co. has initiated a new position in Aclaris Therapeutics, acquiring 217,154 shares valued at $814,000, representing 0.16% of the company. Institutional investors now collectively own 98.34% of Aclaris, which reported a narrower-than-expected quarterly loss and exceeded revenue estimates. Despite remaining unprofitable, analysts …

SEIC main company
Sharemaestro market context Trend signal active 52 weeks +19.4% SEIC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ugly STMicroelectronics Stock May Have Just Signaled a Turnaround

STMicroelectronics (STM) stock has experienced a significant decline recently, dropping nearly 21% in the past month due to disappointing guidance, despite a 109% year-to-date gain. The author suggests that an inductive analysis of past bearish cycles indicates a potential turnaround, targeting a 55/60 bull …

STM main company
Sharemaestro market context Trend signal active 52 weeks +99.1% · Next-week setup positive 55.8% STM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Federal Realty Investment Trust (FRT) Could Be 9% Undervalued As Guidance And Dividend Rise

Federal Realty Investment Trust (FRT) is considered 9% undervalued based on an updated fair value of $131 per share. This positive outlook is supported by increased 2026 earnings guidance, a consistent record of dividend increases, and strategic capital recycling. Despite recent share price gains, …

FRT main company
Sharemaestro market context Trend signal active 52 weeks +23.1% FRT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Atmus Filtration Technologies’s Q2 Earnings Call: Our Top 5 Analyst Questions

Atmus Filtration Technologies (ATMU) reported stronger-than-expected Q2 results, driven by its Koch Filter acquisition and strong performance in Power Solutions. Despite revenue and EPS beats, the company faced margin pressures from increased costs and geopolitical factors. Analysts' questions focused on aftermarket and first-fit revenue …

ATMU main company
Sharemaestro market context Price below Trend Line 52 weeks +16.6% · Next-week setup positive 60.9% ATMU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting

Clover Health's Interim CFO, Joseph Clay Thornton, was granted 54,347 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs, valued at $0, will vest over a four-year period, with 25% vesting on August 12, 2027, and the remainder in quarterly installments, fully …

CLOV main company
Sharemaestro market context Trend signal active 52 weeks +68.5% CLOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PennyMac Mortgage Investment Trust Declares Third Quarter 2026 Dividends for Its Preferred Shares

PennyMac Mortgage Investment Trust (PMT) has announced its third-quarter 2026 cash dividends for its Series A, B, and C Preferred Shares. The dividends per share are $0.507813 for Series A, $0.500000 for Series B, and $0.421875 for Series C, with a record date of …

PMT main company
Sharemaestro market context Price below Trend Line 52 weeks -11.2% PMT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context